Please login to the form below

Not currently logged in
Email:
Password:

aHUS

This page shows the latest aHUS news and features for those working in and with pharma, biotech and healthcare.

Alexion uses priority review voucher for Soliris follow-up

Alexion uses priority review voucher for Soliris follow-up

Ravulizumab is also in late-stage testing for patients with PNH who have been treated with Soliris, as well as those with a typical haemolytic uremic syndrome (aHUS), another rare and

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • NICE and ‘ultra orphans’ NICE and ‘ultra orphans’

    There are currently around 140 people diagnosed with aHUS in England, but and at least another 140 people are estimated to have the condition but be undiagnosed. ... The drug had been assessed in aHUS by AGNSS, which was convinced of its clinical

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics